+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Work-up, evaluation, and treatment planning in patients with head and neck cancer



Work-up, evaluation, and treatment planning in patients with head and neck cancer



Otolaryngologic Clinics of North America 13(3): 413-420



The patient with head and neck cancer requires the recording of a full history and physical examination and a complete evaluation of the local disease; the local findings are viewed against the general medical background. In order to arrive at the optimal treatment, the findings should be reviewed fully at an interdisciplinary conference. In the light of these discussions the responsible team should develop a treatment plan, in concert with the patient and his family whenever possible. The treatment selected should offer the patient the best opportunity for cure, expose him to the last morbidity and expense, and leave him with the most options in the event of a failure. In the early stages of the disease the tendency to overtreat must be avoided.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044988295

Download citation: RISBibTeXText

PMID: 7443235


Related references

Work-up and treatment planning for head and neck cancer. A multi-modality approach. Otolaryngologic Clinics of North America 18(3): 403-409, 1985

Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22). Journal of Pain and Symptom Management 46(1): 113-120, 2014

PET/CT of cancer patients: part 2, deformable registration imaging before and after chemotherapy for radiation treatment planning in head and neck cancer. Ajr. American Journal of Roentgenology 199(5): 968-974, 2013

Quality of life for head and neck cancer patients--has treatment planning altered?. Oral Oncology 45(4-5): 435-439, 2010

Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy. Asian Pacific Journal of Cancer Prevention 15(24): 10899-10903, 2015

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer (): -, 2016

Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Medical Physics 40(8): 081709-081709, 2014

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. Journal of the National Cancer Institute 92(12): 977-986, 2000

Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer. Archives of Otolaryngology--Head & Neck Surgery 135(9): 876-880, 2009

Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction. RadioTherapy and Oncology 107(3): 282-287, 2014

The use of implant retained mandibular prostheses in the oral rehabilitation of head and neck cancer patients. A review and rationale for treatment planning. Oral Oncology 40(9): 862-871, 2004

Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?. International Journal of Radiation Oncology, Biology, Physics 81(4): 943-949, 2012

Preservation of parotid function after external beam irradiation in head and neck cancer patients: A feasibility study using 3-dimensional treatment planning. International Journal of Radiation Oncology Biology Physics 27(3): 731-737, 1993

Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study. Journal of Clinical Oncology 13(7): 1649-1655, 1995